Brain Cancer News and Research

RSS

There are two main types of brain cancer. Primary brain cancer starts in the brain. Metastatic brain cancer starts somewhere else in the body and moves to the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Also called glioma, meningioma.

Synthetic protein nanoparticle may treat aggressive brain cancer

A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

11 Nov 2020

Compound found in brown seaweeds could help treat malignant brain tumour

A compound found in brown seaweeds could help to treat one of the most common and aggressive forms of malignant brain tumour.

10 Nov 2020

Flinders University receives funding for new brain cancer research project

The human brain’s biochemistry may be a stumbling block that has been preventing an effective cure for brain cancer.

10 Nov 2020

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

The Natural Sciences and Engineering Research Council of Canada (NSERC) supports research that results in "breakthrough answers to timeless questions." When choosing awardees, the council looks for creativity and innovation, two qualities they see at the heart of all research advances.

6 Nov 2020

How do low levels of oxygen damage the brain?

In this interview, Professor Paul Tesar and Kevin Allan speak to News-Medical about how low levels of oxygen damage the brain.

6 Nov 2020

Tumor DNA in spinal fluid can help track children with aggressive brain tumors

For many cancers, doctors are increasingly looking to the DNA that solid tumors shed into the blood stream to help with diagnosis and monitoring. But brain cancer has been a different story thanks to the natural blockade created by the blood-brain barrier.

22 Oct 2020

Scientists develop a way to accurately detect and monitor common pediatric brain cancer

A team of scientists at Texas A&M University, Baylor College of Medicine and Texas Children's Hospital have developed a way to more accurately both detect and monitor a common type of pediatric brain cancer, setting the stage for giving clinicians a real-time view into how the cancer responds to treatment.

21 Oct 2020

Scientists may be able to prevent cancer by controlling the ANP32E and H2AZ proteins

Someday, scientists may be able to prevent cancer by controlling two proteins that operate deep inside the quagmire of epigenetic cell fate transitions, a new paper suggests.

21 Oct 2020

Researchers develop new model to observe self-optimization phenomenon in neuronal networks

Researchers at the Cyber-Physical Systems Group at the USC Viterbi School of Engineering, in conjunction with the University of Illinois at Urbana-Champaign, have developed a new model of how information deep in the brain could flow from one network to another and how these neuronal network clusters self-optimize over time.

13 Oct 2020

Researchers develop mitochondrial-targeted prodrug for treating glioblastoma

Houston Methodist researchers found that mice harboring human glioblastoma tumors in their brains had greatly enhanced survival and weight gain when given a newly developed prodrug.

9 Oct 2020

Scientists identify key molecules that mediate radioresistance in aggressive brain cancer

Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of this brain cancer.

30 Sep 2020

Brazilian red propolis contains substances with anti-cancer properties

Brazilian red propolis found in beehives along the coast and mangroves in the Northeast region contains two substances with anti-cancer properties. In laboratory tests, they considerably reduced the proliferation of ovarian, breast, and brain cancer cells

10 Sep 2020

FDA grants rare disease designations to investigational brain tumor drug

The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational drug discovered at the Oklahoma Medical Research Foundation and being developed by Oblato, Inc.

2 Sep 2020

Brain Cancer News and Research

Further Reading

Synthetic protein nanoparticle may treat aggressive brain cancer

Compound found in brown seaweeds could help treat malignant brain tumour

Flinders University receives funding for new brain cancer research project

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

How do low levels of oxygen damage the brain?

Tumor DNA in spinal fluid can help track children with aggressive brain tumors

Scientists develop a way to accurately detect and monitor common pediatric brain cancer

Scientists may be able to prevent cancer by controlling the ANP32E and H2AZ proteins

Researchers develop new model to observe self-optimization phenomenon in neuronal networks

Researchers develop mitochondrial-targeted prodrug for treating glioblastoma

Scientists identify key molecules that mediate radioresistance in aggressive brain cancer

Brazilian red propolis contains substances with anti-cancer properties

FDA grants rare disease designations to investigational brain tumor drug

FEFU scientists to design genetically modified models for understanding malignant gliomas

Researchers find way to make pediatric brain cancers respond better to therapies

Researchers discover how brain cancer cells evade the body's immune system

Removing copper from blood can destroy deadliest cancers that are resistant to immunotherapy

Discoveries point to a new potential treatment approach for fatal childhood brain tumor

A new method to diagnose brain tumors without any incisions

NCI gives 'exceptional' rating to Penn's Abramson Cancer Center

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News